Praxis Bioresearch
Sacramento
About Praxis Bioresearch
Praxis Biosresearch is a privately-held biopharmaceutical company focused on the discovery and development of novel prodrug stimulants for treatment of a range of chronic neuropsychiatric and neurodegenerative disorders. Their lead development candidate prodrug PRX-P4-003 is designed to offer the proven therapeutic benefits of currently marketed stimulants while hindering potential for intravenous abuse.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $2.9M
- Last round: Grant (Aug 2021)
- Website: praxisbioresearch.com
Industries & Categories
Biotechnology, Pharmaceutical
Canonical: https://fsome.com/organization/praxis-bioresearch-28647 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.